Source: Cardiovascular Drugs and Therapy. Unidades: FMRP, FORP
Subjects: ANGIOTENSINAS, METALOPROTEINASES, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONTANA, Vanessa et al. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension. Cardiovascular Drugs and Therapy, v. 26, n. 6, p. 511-519, 2012Tradução . . Disponível em: https://doi.org/10.1007/s10557-012-6420-2. Acesso em: 05 maio 2024.APA
Fontana, V., Silva, P. S., Izidoro-Toledo, T. C., Biagi, C., Oliveira, E. B. de, Gerlach, R. F., & Tanus-Santos, J. E. (2012). Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension. Cardiovascular Drugs and Therapy, 26( 6), 511-519. doi:10.1007/s10557-012-6420-2NLM
Fontana V, Silva PS, Izidoro-Toledo TC, Biagi C, Oliveira EB de, Gerlach RF, Tanus-Santos JE. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension [Internet]. Cardiovascular Drugs and Therapy. 2012 ; 26( 6): 511-519.[citado 2024 maio 05 ] Available from: https://doi.org/10.1007/s10557-012-6420-2Vancouver
Fontana V, Silva PS, Izidoro-Toledo TC, Biagi C, Oliveira EB de, Gerlach RF, Tanus-Santos JE. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension [Internet]. Cardiovascular Drugs and Therapy. 2012 ; 26( 6): 511-519.[citado 2024 maio 05 ] Available from: https://doi.org/10.1007/s10557-012-6420-2
